Sanjaya Sooriarachchi
Family Medicine · Cedar Park, TXNPI 1457442113
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,642 and has fallen 90.9% since, to $149 in 2023.
Across 214 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$695
- Daiichi Sankyo Inc.$538
- Novo Nordisk$470
- GSK$281
- Amgen$277
- AstraZeneca$200
- plus $973 from 20 others
What the payments were for
- Food & beverage$3,426100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $695 |
| Daiichi Sankyo Inc. | 31 | $538 |
| Novo Nordisk | 31 | $470 |
| GSK | 19 | $281 |
| Amgen | 17 | $277 |
| AstraZeneca | 11 | $200 |
| Boehringer Ingelheim | 10 | $199 |
| Johnson & Johnson | 9 | $146 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $83 |
| Biohaven Pharmaceuticals, Inc. | 4 | $78 |
| Lilly USA, LLC | 5 | $71 |
| Abbott | 3 | $63 |
| Astellas Pharma US Inc | 4 | $63 |
| Amarin Pharma, Inc. | 2 | $45 |
| Merck | 2 | $30 |
| IBSA Pharma Inc. | 2 | $28 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Exact Sciences | 1 | $21 |
| Axonics, Inc. | 1 | $18 |
| Novartis | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Bardy Diagnostics, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
How this compares
$3,434 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Cedar Park
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.